[go: up one dir, main page]

WO2007018744A3 - Biosynthese sans cellule d'acide nucleique - Google Patents

Biosynthese sans cellule d'acide nucleique Download PDF

Info

Publication number
WO2007018744A3
WO2007018744A3 PCT/US2006/023439 US2006023439W WO2007018744A3 WO 2007018744 A3 WO2007018744 A3 WO 2007018744A3 US 2006023439 W US2006023439 W US 2006023439W WO 2007018744 A3 WO2007018744 A3 WO 2007018744A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell
bacterial
free
end product
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/023439
Other languages
English (en)
Other versions
WO2007018744A2 (fr
Inventor
Yin Chen
Frederic Kendirgi
Frank Vazquez
Malcolm Skolnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CytoGenix Inc
Original Assignee
CytoGenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/045028 external-priority patent/WO2006063355A2/fr
Application filed by CytoGenix Inc filed Critical CytoGenix Inc
Publication of WO2007018744A2 publication Critical patent/WO2007018744A2/fr
Anticipated expiration legal-status Critical
Publication of WO2007018744A3 publication Critical patent/WO2007018744A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6846—Common amplification features

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un processus permettant de produire un ADN de haute qualité dans un système sans cellule, exempt d'impuretés bactériennes et exempt de manière optimale de séquences codantes pour des gènes bactériens qui peuvent minimiser ou rendre silencieux une expression de gène lorsqu'elle est utilisée pour l'expression à l'intérieur d'une cellule cible. Ce système sans cellule est un procédé rapide qui fournit un produit final hautement fidèle, plus propre convenant pour des applications thérapeutiques avec moins d'efforts et de dépenses et, qui peut être adapté à l'amplification de matrices de type plasmide manquant de séquences de gènes plasmide bactériennes non nécessaires. Ceci permet d'accroître l'efficacité du système et d'accroître l'efficacité du vecteur d'expression de produit final. Ce produit final peut être facilement utilisé comme ADN thérapeutique du fait de la faible incidence des composants de cellule bactérienne et des toxines bactériennes. Cette invention concerne aussi un procédé de production d'ADN pour quelque recherche ou quelque but thérapeutique que ce soit, qui est sensiblement exempt d'impuretés de cellule bactérienne, ainsi qu'une thérapeutique de produit fini comprenant des vaccins ADN.
PCT/US2006/023439 2005-08-03 2006-06-14 Biosynthese sans cellule d'acide nucleique Ceased WO2007018744A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US70534805P 2005-08-04 2005-08-04
US60/705,348 2005-08-04
PCT/US2005/045028 WO2006063355A2 (fr) 2004-12-11 2005-12-12 Biosynthese acellulaire d'acide nucleique de haute qualite et utilisations correspondantes
USPCTUS22000/045028 2005-12-12
US76217206P 2006-01-25 2006-01-25
US60/762,172 2006-01-25

Publications (2)

Publication Number Publication Date
WO2007018744A2 WO2007018744A2 (fr) 2007-02-15
WO2007018744A3 true WO2007018744A3 (fr) 2008-07-03

Family

ID=37728257

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/023439 Ceased WO2007018744A2 (fr) 2005-08-03 2006-06-14 Biosynthese sans cellule d'acide nucleique

Country Status (1)

Country Link
WO (1) WO2007018744A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125845B2 (en) 2008-07-09 2015-09-08 General Electric Company DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
US20100008939A1 (en) * 2008-07-09 2010-01-14 General Electric Company Unprocessed rolling circle amplification product
US8921072B2 (en) 2008-09-02 2014-12-30 General Electric Compnay Methods to generate DNA mini-circles
AU2020351204A1 (en) * 2019-09-18 2022-04-21 Aldevron, Llc Synthetic DNA vectors and methods of use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190608A1 (en) * 1999-11-12 2003-10-09 Gary Blackburn Microfluidic devices comprising biochannels
WO2005003389A2 (fr) * 2003-06-28 2005-01-13 Royal Holloway And Bedford New College Amplification in vitro de l'adn
WO2006063355A2 (fr) * 2004-12-11 2006-06-15 Cytogenix , Inc. Biosynthese acellulaire d'acide nucleique de haute qualite et utilisations correspondantes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190608A1 (en) * 1999-11-12 2003-10-09 Gary Blackburn Microfluidic devices comprising biochannels
WO2005003389A2 (fr) * 2003-06-28 2005-01-13 Royal Holloway And Bedford New College Amplification in vitro de l'adn
WO2006063355A2 (fr) * 2004-12-11 2006-06-15 Cytogenix , Inc. Biosynthese acellulaire d'acide nucleique de haute qualite et utilisations correspondantes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CAMPÀS ET AL: "DNA biochip arraying, detection and amplification strategies", TRENDS IN ANALYTICAL CHEMISTRY, vol. 23, January 2004 (2004-01-01), pages 49 - 62, XP004484688 *
DEAN ET AL: "Rapid amplification of plasmid and phage DNA using Phi29 DNA polymerase and multiply-primed rolling circle amplification", GENOME RESEARCH, vol. 11, 2001, pages 1095 - 1099, XP002261245 *
DEMIDOV: "10 years of rolling the minicircles: RCA assays in DNA diagnostics", EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, vol. 5, July 2005 (2005-07-01), pages 477 - 478, XP009074526 *
LUTHRA ET AL: "Isothermal multiple displacement amplification. A highly reliable approach for generating unlimited high molecular weight genomic DNA from clinical specimens", JOURNAL OF MOLECULAR DIAGNOSTICS, vol. 6, August 2004 (2004-08-01), pages 236 - 242, XP002371240 *
RECTOR ET AL: "A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification", JOURNAL OF VIROLOGY, vol. 78, May 2004 (2004-05-01), pages 4993 - 4998, XP002392144 *
WANG ET AL: "DNA amplification method tolerant to sample degradation", GENOME RESEARCH, vol. 14, November 2004 (2004-11-01), pages 2357 - 2366, XP002391762 *

Also Published As

Publication number Publication date
WO2007018744A2 (fr) 2007-02-15

Similar Documents

Publication Publication Date Title
EP4170029A3 (fr) Modification de la spécificité de molécules d'arn non codantes végétales pour le silençage de l'expression génique
WO2007024756A3 (fr) E. coli a genome reduit
WO2012167192A3 (fr) Procédés et produits pour la production de lignées cellulaires génétiquement modifiées de mammifère par des transgènes amplifiés
WO2005059097A3 (fr) Procedes de production a fidelite elevee de longues molecules d'acide nucleique
HK1259103A1 (zh) 用於在细菌细胞培养物中生产多糖的培养基和发酵方法
WO2003004675A3 (fr) Procede destine a la preparation de l-acides amines au moyen de brins de la famille enterobacteriaceae
WO2008115958A3 (fr) Matières et procédés pour une production efficace de succinate et de malate
WO2008156702A3 (fr) Extinction de gènes médiée par des bactéries
WO2007145612A8 (fr) Séquençage d'extrémités appariées
MX2010009465A (es) Una celula fermentadora de azucar pentosa.
YU55100A (sh) Postupak za fermentacionu proizvodnju d-pantotenske kiseline upotrebom bakterija korinskog oblika
WO2003008610A3 (fr) Procede de fabrication de l-aminoacides au moyen de souches de la famille des enterobacteries contenant un gene pfkb ameliore
NZ600540A (en) Ethanol production in non-recombinant hosts
EP2173901A4 (fr) Modulation de gènes induite par des bactéries via micro-arn
EP4406615A3 (fr) Procédé de production d'une immunoglobuline glycosylée
AU2002235933A1 (en) Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated acea gene
WO2005033094A3 (fr) Procedes pour produire du 3-methylamino-1-(thien-2-yl)-propan-1-ol
WO2005089735A3 (fr) Compositions et procédés servant à traiter un cancer des poumons
WO2010064262A3 (fr) Procédé pour la production de mélanine hydrosoluble utilisant une souche du champignon gliocephalotrichum
WO2003040681A3 (fr) Genes codant des proteines de la voie metabolique
AU2002333878A1 (en) A process for the production of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced fadr or iclr gene
WO2007018744A3 (fr) Biosynthese sans cellule d'acide nucleique
WO2021231263A3 (fr) Procédés d'amplification d'acides nucléiques
JP2011527367A5 (fr)
WO2011000998A3 (fr) Méthode de réplication, d'amplification ou de séquençage d'une adn matrice

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06773321

Country of ref document: EP

Kind code of ref document: A2